Taussig MJ, Stoevesandt O, Borrebaeck CAK, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R, Gibson TJ, Gloriam D, Gold L, Herberg FW, Hermjakob H, Hoheisel JD, Joos TO, Kallioniemi O, Koegl M, Koegll M, Konthur Z, Korn B, Kremmer E, Krobitsch S, Landegren U, van der Maarel S, McCafferty J, Muyldermans S, Nygren P-A, Palcy S, Plückthun A, Polic B, Przybylski M, Saviranta P, Sawyer A, Sherman DJ, Skerra A, Templin M, Ueffing M, Uhlén M: ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods. 2007, 4: 13-17. 10.1038/nmeth0107-13.
Article
CAS
Google Scholar
Dübel S, Stoevesandt O, Taussig MJ, Hust M: Generating recombinant antibodies to the complete human proteome. Trends Biotechnol. 2010, 28: 333-339. 10.1016/j.tibtech.2010.05.001.
Article
Google Scholar
Colwill K, Gräslund S: A roadmap to generate renewable protein binders to the human proteome. Nat Methods. 2011, 8: 551-558. 10.1038/nmeth.1607.
Article
CAS
Google Scholar
Hust M, Meyer T, Voedisch B, Rülker T, Thie H, El-Ghezal A, Kirsch MI, Schütte M, Helmsing S, Meier D, Schirrmann T, Dübel S: A human scFv antibody generation pipeline for proteome research. J Biotechnol. 2011, 152: 159-170. 10.1016/j.jbiotec.2010.09.945.
Article
CAS
Google Scholar
Hust M, Steinwand M, Al-Halabi L, Helmsing S, Schirrmann T, Dübel S: Improved microtitre plate production of single chain Fv fragments in Escherichia coli. N Biotechnol. 2009, 25: 424-428. 10.1016/j.nbt.2009.03.004.
Article
CAS
Google Scholar
Shu L, Qi CF, Schlom J, Kashmiri SV: Secretion of a single-gene-encoded immunoglobulin from myeloma cells. PNAS. 1993, 90: 7995-7999. 10.1073/pnas.90.17.7995.
Article
CAS
Google Scholar
Moutel S, El Marjou A, Vielemeyer O, Nizak C, Benaroch P, Dübel S, Perez F: A multi-Fc-species system for recombinant antibody production. BMC Biotechnol. 2009, 9: 14-10.1186/1472-6750-9-14.
Article
Google Scholar
Thie H, Toleikis L, Li J, von Wasielewski R, Bastert G, Schirrmann T, Esteves IT, Behrens CK, Fournes B, Fournier N, de Romeuf C, Hust M, Dübel S: Rise and fall of an anti-MUC1 specific antibody. PLoS One. 2011, 6: e15921-10.1371/journal.pone.0015921.
Article
CAS
Google Scholar
Kirsch MI, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall H-J, Hust M, Dübel S: Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol. 2008, 8: 66-10.1186/1472-6750-8-66.
Article
Google Scholar
Girgis MD, Olafsen T, Kenanova V, McCabe KE, Wu AM, Tomlinson JS: Targeting CEA in pancreas cancer xenografts with a Mutated scFv-Fc antibody fragment. EJNMMI Res. 2011, 1: 24-10.1186/2191-219X-1-24.
Article
Google Scholar
Menzel C, Schirrmann T, Konthur Z, Jostock T, Dübel S: Human antibody RNase fusion protein targeting CD30+ lymphomas. Blood. 2008, 111: 3830-3837. 10.1182/blood-2007-04-082768.
Article
CAS
Google Scholar
Shen Z, Stryker GA, Mernaugh RL, Yu L, Yan H, Zeng X: Single-chain fragment variable antibody piezoimmunosensors. Anal Chem. 2005, 77: 797-805. 10.1021/ac048655w.
Article
CAS
Google Scholar
Al-Halabi L, Balck A, Michalzik M, Fröde D, Büttgenbach S, Hust M, Schirrmann T, Dubel S: Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor. MAbs. 2013, 5: 0-1.
Article
CAS
Google Scholar
Pohl SC, Schwarz S, Frenzel A, Schirrmann T: A cassette vector system for the rapid cloning and production of bispecific tetravalent antibodies. Antibodies. 2012, 1: 19-38. 10.3390/antib1010019.
Article
CAS
Google Scholar
Schirrmann T, Pecher G: Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo. Cancer Gene Ther. 2002, 9: 390-398. 10.1038/sj.cgt.7700453.
Article
CAS
Google Scholar
Schirrmann T, Pecher G: Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor. Leuk Res. 2005, 29: 301-306. 10.1016/j.leukres.2004.07.005.
Article
CAS
Google Scholar
Capodicasa C, Chiani P, Bromuro C, De Bernardis F, Catellani M, Palma AS, Liu Y, Feizi T, Cassone A, Benvenuto E, Torosantucci A: Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans. Plant Biotechnol J. 2011, 9: 776-787. 10.1111/j.1467-7652.2010.00586.x.
Article
CAS
Google Scholar
Rülker T, Voß L, Thullier P, O’ Brien LM, Pelat T, Langermann C, Schirrmann T, Dübel S, Marschall H-J, Hust M, Hülseweh B: Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV In Vitro and In Vivo. PLoS One. 2012, 7: e37242-10.1371/journal.pone.0037242.
Article
Google Scholar
West AP, Galimidi RP, Gnanapragasam PNP, Bjorkman PJ: Single-chain Fv-based anti-HIV proteins: potential and limitations. J Virol. 2012, 86: 195-202. 10.1128/JVI.05848-11.
Article
CAS
Google Scholar
Liu J, Wei D, Qian F, Zhou Y, Wang J, Ma Y, Han Z: pPIC9-Fc: a vector system for the production of single-chain Fv-Fc fusions in Pichia pastoris as detection reagents in vitro. J Biochem. 2003, 134: 911-917. 10.1093/jb/mvg222.
Article
CAS
Google Scholar
Zhang N, Liu L, Dumitru CD, Cummings NRH, Cukan M, Jiang Y, Li Y, Li F, Mitchell T, Mallem MR, Ou Y, Patel RN, Vo K, Wang H, Burnina I, Choi B-K, Huber HE, Stadheim TA, Zha D: Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. MAbs. 2011, 3: 289-298. 10.4161/mabs.3.3.15532.
Article
Google Scholar
Ye J, Ly J, Watts K, Hsu A, Walker A, McLaughlin K, Berdichevsky M, Prinz B, Sean Kersey D, d’ Anjou M, Pollard D, Potgieter T: Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production. Biotechnol Prog. 2011, 27: 1744-1750. 10.1002/btpr.695.
Article
CAS
Google Scholar
Jiang Y, Li F, Button M, Cukan M, Moore R, Sharkey N, Li H: A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris. Protein Expr Purif. 2010, 74: 9-15. 10.1016/j.pep.2010.04.016.
Article
CAS
Google Scholar
Schirrmann T, Al-Halabi L, Dübel S, Hust M: Production systems for recombinant antibodies. Front Biosci. 2008, 13: 4576-4594.
Article
CAS
Google Scholar
Wurm FM: Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004, 22: 1393-1398. 10.1038/nbt1026.
Article
CAS
Google Scholar
Jostock T: Expression of antibody in mammalian cells. Antibody Expression and Production. Edited by: Al-Rubeai M. 2011, Heidelberg: Springer, 1-24. [Cell Engineering, vol. 7]
Chapter
Google Scholar
Wilke S, Groebe L, Maffenbeier V, Jäger V, Gossen M, Josewski J, Duda A, Polle L, Owens RJ, Wirth D, Heinz DW, van den Heuvel J, Büssow K: Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line development. PLoS One. 2011, 6: e27829-10.1371/journal.pone.0027829.
Article
CAS
Google Scholar
Geisse S, Fux C: Recombinant protein production by transient gene transfer into mammalian cells. Meth. Enzymol. 2009, 463: 223-238.
Article
CAS
Google Scholar
Baldi L, Hacker DL, Adam M, Wurm FM: Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett. 2007, 29: 677-684. 10.1007/s10529-006-9297-y.
Article
CAS
Google Scholar
Jostock T, Vanhove M, Brepoels E, Van Gool R, Daukandt M, Wehnert A, Van Hegelsom R, Dransfield D, Sexton D, Devlin M, Ley A, Hoogenboom H, Müllberg J: Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries. J Immunol Methods. 2004, 289: 65-80. 10.1016/j.jim.2004.03.014.
Article
CAS
Google Scholar
Geisse S, Henke M: Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics. 2005, 6: 165-170. 10.1007/s10969-005-2826-4.
Article
CAS
Google Scholar
Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM: Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res. 2008, 36: e96-10.1093/nar/gkn423.
Article
Google Scholar
Tuvesson O, Uhe C, Rozkov A, Lüllau E: Development of a generic transient transfection process at 100 L scale. Cytotechnology. 2008, 56: 123-136. 10.1007/s10616-008-9135-2.
Article
CAS
Google Scholar
Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM: Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng. 2001, 75: 197-203. 10.1002/bit.1179.
Article
CAS
Google Scholar
Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. PNAS. 1995, 92: 7297-7301. 10.1073/pnas.92.16.7297.
Article
CAS
Google Scholar
Boussif O, Zanta MA, Behr JP: Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 1996, 3: 1074-1080.
CAS
Google Scholar
Thomas M, Klibanov AM: Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells. PNAS. 2002, 99: 14640-14645. 10.1073/pnas.192581499.
Article
CAS
Google Scholar
Schirrmann T, Büssow K: Transient production of scFv-Fc fusion proteins in mammalian cells. Antibody Engineering. Edited by: Kontermann R, Dübel S. 2010, Berlin, Heidelberg: Springer Berlin Heidelberg, 387-398.
Chapter
Google Scholar
Schlaeger EJ, Christensen K: Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology. 1999, 30: 71-83. 10.1023/A:1008000327766.
Article
CAS
Google Scholar
Wurm F, Bernard A: Large-scale transient expression in mammalian cells for recombinant protein production. Curr Opin Biotechnol. 1999, 10: 156-159. 10.1016/S0958-1669(99)80027-5.
Article
CAS
Google Scholar
Durocher Y, Perret S, Kamen A: High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002, 30: E9-10.1093/nar/30.2.e9.
Article
Google Scholar
Swiech K, Kamen A, Ansorge S, Durocher Y, Picanço-Castro V, Russo-Carbolante EM, Neto MS, Covas DT: Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII. BMC Biotechnol. 2011, 11: 114-10.1186/1472-6750-11-114.
Article
CAS
Google Scholar
Godbey WT, Wu KK, Mikos AG: Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. PNAS. 1999, 96: 5177-5181. 10.1073/pnas.96.9.5177.
Article
CAS
Google Scholar
Loignon M, Perret S, Kelly J, Boulais D, Cass B, Bisson L, Afkhamizarreh F, Durocher Y: Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol. 2008, 8: 65-10.1186/1472-6750-8-65.
Article
Google Scholar
Zhang J, Liu X, Bell A, To R, Baral TN, Azizi A, Li J, Cass B, Durocher Y: Transient expression and purification of chimeric heavy chain antibodies. Protein Expr Purif. 2009, 65: 77-82. 10.1016/j.pep.2008.10.011.
Article
CAS
Google Scholar
Kozak M: At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol. 1987, 196: 947-950. 10.1016/0022-2836(87)90418-9.
Article
CAS
Google Scholar
Kozak M: An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987, 15: 8125-8148. 10.1093/nar/15.20.8125.
Article
CAS
Google Scholar
Brown CM, Stockwell PA, Trotman CN, Tate WP: Sequence analysis suggests that tetra-nucleotides signal the termination of protein synthesis in eukaryotes. Nucleic Acids Res. 1990, 18: 6339-6345. 10.1093/nar/18.21.6339.
Article
CAS
Google Scholar
McCaughan KK, Brown CM, Dalphin ME, Berry MJ, Tate WP: Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci USA. 1995, 92: 5431-5435. 10.1073/pnas.92.12.5431.
Article
CAS
Google Scholar
Deb S, DeLucia AL, Baur CP, Koff A, Tegtmeyer P: Domain structure of the simian virus 40 core origin of replication. Mol Cell Biol. 1986, 6: 1663-1670.
Article
CAS
Google Scholar
Frenzel A, Fröde D, Meyer T, Schirrmann T, Hust M: Generating recombinant antibodies for research, diagnostics and therapy using phage display. Current Biotech. 2012, 1: 33-41. 10.2174/2211550111201010033.
Article
CAS
Google Scholar
Pham PL, Kamen A, Durocher Y: Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol. 2006, 34: 225-237. 10.1385/MB:34:2:225.
Article
CAS
Google Scholar
Längle-Rouault F, Patzel V, Benavente A, Taillez M, Silvestre N, Bompard A, Sczakiel G, Jacobs E, Rittner K: Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol. 1998, 72: 6181-6185.
Google Scholar
Li J-H, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu F-F: Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res. 2002, 62: 171-178.
CAS
Google Scholar
Zuo Y, Wu J, Xu Z, Yang S, Yan H, Tan L, Meng X, Ying X, Liu R, Kang T, Huang W: Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 2011, 6: e19407-10.1371/journal.pone.0019407.
Article
CAS
Google Scholar
Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM: Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng. 2008, 101: 182-189. 10.1002/bit.21882.
Article
CAS
Google Scholar
Wulhfard S, Baldi L, Hacker DL, Wurm F: Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol. 2010, 148: 128-132. 10.1016/j.jbiotec.2010.05.003.
Article
CAS
Google Scholar
Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, Regnier L, Ehrenmann F, Lefranc G, Duroux P: IMGT(R), the international ImMunoGeneTics information system(R). Nucleic Acids Res. 2009, 37: D1006-D1012. 10.1093/nar/gkn838.
Article
CAS
Google Scholar
Meinke G, Phelan P, Moine S, Bochkareva E, Bochkarev A, Bullock PA, Bohm A: The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS Biol. 2007, 5: e23-10.1371/journal.pbio.0050023.
Article
Google Scholar
Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A: A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. 2002, 20: 87-90. 10.1038/nbt0102-87.
Article
CAS
Google Scholar
Rülker T, Meier D, Schirrmann T: Quantification of human IgG and related Fc fusion proteins by a human IgG/Fc capture ELISA. Antibody Engineering. Edited by: Kontermann R, Dübel S. 2010, Berlin, Heidelberg: Springer Berlin Heidelberg, 743-748.
Chapter
Google Scholar